Diabetes drug metformin may slow cataract cell growth
NCT ID NCT07176338
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 37 times
Summary
This pilot study looks at how the diabetes drug metformin gets into the lens of the eye and whether it can slow the growth of lens cells that cause cataracts. Researchers will measure metformin levels in lens capsules and blood from 40 diabetic patients having cataract surgery. The goal is to understand if metformin might help prevent or delay cataracts in people with type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vienna Institute for Research in Ocular Surgery (VIROS)
Vienna, 1140, Austria
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.